Article

Canadian researchers describe novel 'uveolymphatic pathway'

Lymphatic vessels exist in the human ciliary body, and this novel "uveolymphatic" system appears to be rich and complex, according to Neeru Gupta, MD, PhD.

Lymphatic vessels exist in the human ciliary body, and this novel "uveolymphatic" system appears to be rich and complex, according to Neeru Gupta, MD, PhD.

Dr. Gupta, University of Toronto, Canada, presented research using immunostaining techniques and confocal laser microscopy to investigate the presence of a lymphatic circulatory system in the ciliary body. The studies were performed using human eye sections obtained from the Eye Bank of Canada.

The results showed lymphatic channels were present in the circular, radial, and longitudinal portions of the ciliary muscle, stroma, and ciliary processes as well as around blood vessels within the ciliary body. Comparisons between healthy eyes and eyes from similarly aged donors with primary open-angle glaucoma showed a reduction in lymphatics in the glaucomatous eyes.

"It is generally accepted that there are no lymphatics inside the eye, but their presence in the human ciliary body has not been investigated," Dr. Gupta said. "Our identification of a uveolymphatic pathway is entirely in keeping with the well-known functions of the lymphatic system, which include drainage of extracellular fluid, removal of solutes, and immune surveillance.

"Now, further research is needed to understand the physiologic significance of this anatomic finding in normal eyes, to determine how its alteration might contribute to elevated IOP in glaucoma, and to investigate whether the lymphatic vessels of the ciliary body are a novel target for existing and new glaucoma therapies," Dr. Gupta said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.